(Q37117363)

18 August 2017

1 reference

title

Bisphosphonates in the treatment of thalassemia-associated osteoporosis (English)

1 reference

18 August 2017

0 references

Gaudio A

1

1 reference

18 August 2017

Morabito N

2

1 reference

18 August 2017

Xourafa A

3

1 reference

18 August 2017

Macrì I

4

1 reference

18 August 2017

Meo A

5

1 reference

18 August 2017

Morgante S

6

1 reference

18 August 2017

Trifiletti A

7

1 reference

18 August 2017

Lasco A

8

1 reference

18 August 2017

Frisina N

9

1 reference

18 August 2017

1 February 2008

1 reference

Journal of Endocrinological Investigation

18 August 2017

1 reference

18 August 2017

31

1 reference

18 August 2017

181-184

1 reference

18 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03345587

18 August 2017

0 references

cites work

Prevalence of fractures among the Thalassemia syndromes in North America

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Bone resorption is increased in young adults with thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Hypogonadism and Hormone Replacement Therapy on Bone Mass of Adult Women with Thalassemia Major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Regulation of osteoclast function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

New bisphosphonates in the treatment of bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Bisphosphonates in the treatment of thalassemia-induced osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Treatment of beta-thalassaemia-associated osteoporosis with zoledronic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Bisphosphonate-induced osteonecrosis of the jaw.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

New approaches for interpreting projected bone densitometry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345587

Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial

21 January 2018

1 reference

12 December 2020

Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants

1 reference

12 December 2020

Effects of iron overload on bone remodeling in pigs.

1 reference

12 December 2020

Multicentre study on prevalence of fractures in transfusion-dependent thalassaemic patients

1 reference

12 December 2020

High incidence of osteoporosis in thalassaemia major

1 reference

12 December 2020

Bisphosphonates: mechanisms of action

1 reference

12 December 2020

Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia

1 reference

12 December 2020

Genetic and acquired predisposing factors and treatment of osteoporosis in thalassaemia major.

1 reference

12 December 2020

Bone density: BMC, BMD, or corrected BMD?

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345587

1 reference

18 August 2017

1 reference